Home Cart Sign in  
Chemical Structure| 1423186-80-4 Chemical Structure| 1423186-80-4

Structure of GSK2983559 active metabolite
CAS No.: 1423186-80-4

Chemical Structure| 1423186-80-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

RIP2 kinase inhibitor 1 is a receptor interacting protein-2 (RIP2) kinase inhibitor.

Synonyms: GSK2983559 active metabolite

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK2983559 active metabolite

CAS No. :1423186-80-4
Formula : C21H22N4O4S2
M.W : 458.55
SMILES Code : O=S(C1=CC2=C(NC3=CC=C(SC=N4)C4=C3)N=CN=C2C=C1OCCO)(C(C)(C)C)=O
Synonyms :
GSK2983559 active metabolite
MDL No. :N/A

Safety of GSK2983559 active metabolite

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of GSK2983559 active metabolite

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
786-O cells 3 μM Inhibition of RIPK2 activity significantly reduced the proliferation and migration ability of 786-O cells PMC8064209

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 wild-type mice Middle cerebral artery occlusion (MCAO) model Intraventricular injection 3 μl of 200 μM Single dose, 30 min before MCAO To investigate the effect of RIP2 inhibitor GSK559 on cerebral ischemic outcomes, results showed that pretreatment with GSK559 attenuated neurological deficit score and reduced infarction volume PMC10680203
BALB/c nude mice 786-O cell xenograft model 50 mg/kg Twice daily GSK2983559 significantly inhibited the tumor growth of 786-O cells in nude mice PMC8064209

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.18mL

0.44mL

0.22mL

10.90mL

2.18mL

1.09mL

21.81mL

4.36mL

2.18mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories